Surgery Partners (NASDAQ:SGRY) Research Coverage Started at UBS Group

UBS Group assumed coverage on shares of Surgery Partners (NASDAQ:SGRY) in a report published on Monday, Marketbeat reports. The firm issued a buy rating and a $38.00 price objective on the stock.

A number of other equities research analysts have also commented on the company. KeyCorp started coverage on Surgery Partners in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Citigroup reduced their price objective on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Macquarie began coverage on Surgery Partners in a report on Friday, June 28th. They set an “outperform” rating and a $31.00 price objective on the stock. StockNews.com downgraded Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $49.00 price objective on shares of Surgery Partners in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $39.63.

Surgery Partners Stock Up 2.5 %

NASDAQ SGRY opened at $32.68 on Monday. The firm has a market cap of $4.15 billion, a PE ratio of -121.03, a price-to-earnings-growth ratio of 2.33 and a beta of 2.75. Surgery Partners has a one year low of $22.05 and a one year high of $36.92. The stock’s 50 day simple moving average is $30.98 and its 200 day simple moving average is $27.87. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.83 and a quick ratio of 1.69.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. The business had revenue of $762.10 million for the quarter, compared to analyst estimates of $735.94 million. Surgery Partners had a positive return on equity of 2.96% and a negative net margin of 1.17%. Surgery Partners’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.25 EPS. As a group, sell-side analysts forecast that Surgery Partners will post 0.86 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in SGRY. Janus Henderson Group PLC lifted its stake in shares of Surgery Partners by 7,987.1% in the 1st quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock valued at $74,701,000 after purchasing an additional 2,473,282 shares during the period. Deerfield Management Company L.P. Series C raised its stake in Surgery Partners by 47.7% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company’s stock worth $111,986,000 after buying an additional 1,520,484 shares during the period. Point72 Asset Management L.P. acquired a new stake in Surgery Partners during the 2nd quarter worth $29,288,000. Vanguard Group Inc. raised its stake in Surgery Partners by 10.4% during the 4th quarter. Vanguard Group Inc. now owns 7,417,609 shares of the company’s stock worth $237,289,000 after buying an additional 698,845 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in Surgery Partners by 26.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company’s stock worth $66,643,000 after buying an additional 589,499 shares during the period.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.